Apyx Medical Corp Adopts 2026 Share Incentive Plan

What Happened Apyx Medical Corporation announced in a Form 8-K filed August 7, 2026 that its stockholders approved the adoption of the company's 2026 Share Incentive Plan at the 2026 Annual Meeting. A summary of the plan appears under “Approval of the 2026 Share Incentive Plan” in Apyx’s definitive proxy statement filed June 26, 2026, and the full text of the plan is attached to the 8-K as Exhibit 10.1.

Key Details

• Stockholders approved the adoption of the 2026 Share Incentive Plan at the 2026 Annual Meeting.
• Summary of the plan is included in the company’s Proxy Statement filed June 26, 2026 (under the “Approval of the 2026 Share Incentive Plan” heading).
• The complete 2026 Share Incentive Plan is filed as Exhibit 10.1 to the Form 8-K (filed August 7, 2026).

Why It Matters Adoption of a share incentive plan gives the company a structured way to grant equity-based compensation (such as stock options or restricted stock) to employees, directors and consultants, which can help align management and employee incentives with shareholder interests. Such plans can also increase the number of shares outstanding over time, so investors should review the full plan text (Exhibit 10.1) and the Proxy Statement to understand the authorized share reserve, grant terms, vesting, and potential dilution.